Cisco Beats Q3 Estimates and Boosts 2026 Guidance
Cisco beat expectations, raised its outlook, and saw strong AI demand, while announcing a restructuring plan and job cuts.
Already have an account? Sign in.
Cisco beat expectations, raised its outlook, and saw strong AI demand, while announcing a restructuring plan and job cuts.
Roth Capital maintains a Buy rating with a $9 price target despite the post-deal share decline.
BMO Capital gives Trevi Therapeutics an Outperform rating and $36 target, citing strong potential for Haduvio as a first-in-class treatment for chronic cough in idiopathic pulmonary fibrosis.
Analyst forecasts show Intel and Samsung struggling to close the gap on A16 and N2 technology.